Company information:
Neoceuticals Limited (No: 05421610)
Address: THE CATALYST, BAIRD LANE, HESLINGTON, YORK, YO10 5GA, UNITED KINGDOM
Status: Active
Incorporated: 04-Dec-2005
Accounts Next Due: 30-Sep-2025
Next Confirmation Statement Due: 23-Oct-2024
Industry Class: 21100 - Manufacture of basic pharmaceutical products
Current Director: NUO CHEN ( DOB: Aug-1968 From: Sep-2021 )
Current Director: BEINING CHEN ( DOB: May-1964 From: Oct-2021 )
Current Director: HONG YI ( DOB: Sep-1982 From: Sep-2021 )
Resigned Director: RODNEY HARRY ADAMS ( DOB: Dec-1944 From: Nov-2007 To: Sep-2021 )
Resigned Director: BRENDA MARGARET ADAMS ( DOB: Jul-1942 From: Jun-2010 To: Sep-2021 )
Resigned Director: ANDREW BRODRICK ( DOB: Jul-1951 From: Dec-2005 To: Sep-2021 )
Resigned Director: DEBORAH JANE BRODRICK ( DOB: Apr-1953 From: Dec-2005 To: Sep-2021 )
Resigned Director: JAMES PHILIP LEWIS OGDEN ( DOB: Oct-1961 From: Apr-2005 To: Dec-2005 )
Resigned Secretary: JAMES PHILIP LEWIS OGDEN ( DOB: Oct-1961 From: Apr-2006 To: Aug-2008 )
Resigned Secretary: SUSAN PROCTOR ( DOB: Nov-1958 From: Aug-2008 To: Sep-2021 )
Resigned Secretary: CHARLES ROBERT WALKER ( DOB: Jun-1963 From: Apr-2005 To: Apr-2006 )
Persons of Significant Control:
Dr Rodney Harry Adams, 6 Deans Lane, Pocklington, York, YO42 2PX, England: Right to appoint and remove directors, Has significant influence or control (Notified: 2016-04-06, Ceased: 2021-09-06)
Mr. Hong Yi, Room 101, Building 5 Herunyuan Garden Room 101, Building 5 Herunyuan Garden, 18 Zhujin Road, Qingxiu District, Nanning City, Guangxi Province, 530025, China: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2021-09-06)
Dr Andrew Brodrick, 6 Deans Lane, Pocklington, York, YO42 2PX, England: Right to appoint and remove directors, Has significant influence or control (Notified: 2016-04-06, Ceased: 2021-09-06)
Company Accounts Summary (£)
| Item | 16 | 17 | 18 | 19 | 20 | 21 | 22 | Chart |
|---|---|---|---|---|---|---|---|---|
| Current assets | 295,404 | 683,471 | 664,964 | 605,947 | 623,742 | 666,648 | 953,741 | 295404.0,683471.0,664964.0,605947.0,623742.0,666648.0,953741.0 |
| Current assets / Total inventories | 104,454 | 131,853 | 296,097 | 194,315 | 237,791 | 195,196 | 192,059 | 104454.0,131853.0,296097.0,194315.0,237791.0,195196.0,192059.0 |
| Current assets / Debtors | 111,633 | 431,398 | 183,890 | 273,773 | 143,713 | 276,742 | 387,802 | 111633.0,431398.0,183890.0,273773.0,143713.0,276742.0,387802.0 |
| Current assets / Debtors / Trade debtors / trade receivables | 109,824 | 109824.0,0.0,0.0,0.0,0.0,0.0,0.0 | ||||||
| Current assets / Cash at bank and on hand | 79,317 | 120,220 | 184,977 | 137,859 | 242,238 | 194,710 | 373,880 | 79317.0,120220.0,184977.0,137859.0,242238.0,194710.0,373880.0 |
| Net current assets (liabilities) | 155,820 | 434,991 | 343,888 | 419,750 | 379,836 | 392,354 | 776,481 | 155820.0,434991.0,343888.0,419750.0,379836.0,392354.0,776481.0 |
| Equity / share capital and reserves | 155,820 | 434,991 | 289,432 | 369,750 | 329,836 | 392,354 | 776,481 | 155820.0,434991.0,289432.0,369750.0,329836.0,392354.0,776481.0 |